Eosinophilic Lung Diseases

Immunol Allergy Clin North Am. 2023 May;43(2):289-322. doi: 10.1016/j.iac.2023.01.002.

Abstract

The eosinophilic lung diseases may manifest as chronic eosinophilic pneumonia, acute eosinophilic pneumonia, or as the Löffler syndrome (generally of parasitic etiology). The diagnosis of eosinophilic pneumonia is made when both characteristic clinical-imaging features and alveolar eosinophilia are present. Peripheral blood eosinophils are generally markedly elevated; however, eosinophilia may be absent at presentation. Lung biopsy is not indicated except in atypical cases after multidisciplinary discussion. The inquiry to possible causes (medications, toxic drugs, exposures, and infections especially parasitic) must be meticulous. Idiopathic acute eosinophilic pneumonia may be misdiagnosed as infectious pneumonia. Extrathoracic manifestations raise the suspicion of a systemic disease especially eosinophilic granulomatosis with polyangiitis. Airflow obstruction is frequent in allergic bronchopulmonary aspergillosis, idiopathic chronic eosinophilic pneumonia, eosinophilic granulomatosis with polyangiitis, and hypereosinophilic obliterative bronchiolitis. Corticosteroids are the cornerstone of therapy, but relapses are common. Therapies targeting interleukin 5/interleukin-5 are increasingly used in eosinophilic lung diseases.

Keywords: Aspergillus; Eosinophil; Eosinophilic granulomatosis with polyangiitis; Eosinophilic pneumonia; Interstitial lung disease.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Churg-Strauss Syndrome* / diagnosis
  • Granulomatosis with Polyangiitis*
  • Humans
  • Lung
  • Lung Diseases*
  • Pulmonary Eosinophilia* / drug therapy
  • Pulmonary Eosinophilia* / therapy